Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Olmetec Plus
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Olmetec Plus 20mg/12.5mg tablets
0205052Y0BBAAAA
|
Olmetec Plus | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 236 |
|
Olmetec Plus 40mg/12.5mg tablets
0205052Y0BBACAC
|
Olmetec Plus | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 133 |
|
Olmetec Plus 20mg/25mg tablets
0205052Y0BBABAB
|
Olmetec Plus | Olmesartan medoxomil/hydrochlorothiazide | Cardiovascular System | 62 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.